We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.99B
AUM Growth
+$284M
Cap. Flow
+$258M
Cap. Flow %
12.95%
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Consumer Discretionary 13.01%
3 Healthcare 12.59%
4 Industrials 12.57%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBLK icon
976
Star Bulk Carriers
SBLK
$3.12B
$354K 0.02%
27,528
+12,069
+78% +$154K
WCG
977
DELISTED
Wellcare Health Plans, Inc.
WCG
$354K 0.02%
1,436
-1,163
-45% -$253K
CHL
978
DELISTED
China Mobile Limited
CHL
$354K 0.02%
7,976
+481
+6% +$22.1K
BHVN
979
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$354K 0.02%
+8,963
New +$284K
BHC icon
980
Bausch Health
BHC
$2.35B
$353K 0.02%
15,159
-12,857
-46% -$266K
BCE icon
981
BCE
BCE
$20.6B
$352K 0.02%
8,691
+6,103
+236% +$256K
OKE icon
982
Oneok
OKE
$55B
$352K 0.02%
+5,038
New +$324K
TAP icon
983
Molson Coors Class B
TAP
$7.85B
$352K 0.02%
5,177
-1,490
-22% -$99.3K
DPLO
984
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$352K 0.02%
13,780
+11,453
+492% +$267K
CCL icon
985
Carnival Corporation Ltd
CCL
$40.6B
$351K 0.02%
6,125
-18,224
-75% -$1.16M
CNO icon
986
CNO Financial Group
CNO
$5.16B
$351K 0.02%
18,421
-44,274
-71% -$916K
FAF icon
987
First American
FAF
$7.66B
$351K 0.02%
6,792
-9,766
-59% -$521K
CHS
988
DELISTED
Chicos FAS, Inc.
CHS
$348K 0.02%
42,724
+27,322
+177% +$259K
APEI icon
989
American Public Education
APEI
$987M
$347K 0.02%
8,235
-1,093
-12% -$45.7K
OOMA icon
990
Ooma
OOMA
$590M
$347K 0.02%
24,520
-1,200
-5% -$14.1K
PARR icon
991
Par Pacific Holdings
PARR
$3.51B
$347K 0.02%
+19,993
New +$355K
ROST icon
992
Ross Stores
ROST
$81.2B
$347K 0.02%
4,100
-15,118
-79% -$1.23M
NTLA icon
993
Intellia Therapeutics
NTLA
$1.53B
$346K 0.02%
12,653
+709
+6% +$17.2K
NKTR icon
994
Nektar Therapeutics
NKTR
$2.47B
$344K 0.02%
470
-2,397
-84% -$2.76M
DAY
995
DELISTED
Dayforce
DAY
$344K 0.02%
+10,377
New +$365K
CBD
996
DELISTED
Companhia Brasileira de Distribuicao
CBD
$344K 0.02%
+17,234
New +$361K
IDTI
997
DELISTED
Integrated Device Technology I
IDTI
$344K 0.02%
10,779
-12
-0.1% -$381
SM icon
998
SM Energy
SM
$6.96B
$342K 0.02%
13,330
+563
+4% +$13.2K
TTWO icon
999
Take-Two Interactive
TTWO
$43.9B
$342K 0.02%
2,893
-15,635
-84% -$1.7M
VRNS icon
1000
Varonis Systems
VRNS
$4.98B
$342K 0.02%
13,782
+11,070
+408% +$265K

Similar funds

Cubist Systematic Strategies's Q2 2018 Portfolio in Review

As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.

  • Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
  • Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
  • Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
  • Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
  • Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
  • Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.